header
Image from OpenLibrary

Real - time PCR assay of VKORC1 and CYP2C9 gene polymorphisms that affect warfarin response / Sherif Mofeed Megalla Ekladious ; Supervised Hazem Elsayed Abouyoussef , Sahar Abdelatty Sharaf , Marianne Samir Makboul

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Sherif Mofeed Megalla Ekladious , 2012Description: 127P. : charts , facsimiles ; 25cmOther title:
  • استخدام تفاعل البلمرة المتسلسل فى الزمن الحقيقى لاكتشاف الأشكال الجينية للجين CYP2C9والجينVKORC1 اللذان يؤثران على الاستجابة لدواء الوارفارين [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Warfarin is a commonly used oral anticoagulant with a narrow therapeutic index and various genetic and clinical factors that influence interpatient variability in dose requirements . This study investigated the impact of genetic and nongenetic factors on warfarin dose requirements in Egyptians . DNA was extracted from 50 patients taking warfarin for more than 1 year and genotyped for VKORC1 (1173 C> T) , CYP2C9 *3 (1075 C>)gene polymorphisms using SYBR Green - based multiplex allele - specific PCR
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2012.Sh.R (Browse shelf(Opens below)) Not for loan 01010110058757000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2012.Sh.R (Browse shelf(Opens below)) 58757.CD Not for loan 01020110058757000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Warfarin is a commonly used oral anticoagulant with a narrow therapeutic index and various genetic and clinical factors that influence interpatient variability in dose requirements . This study investigated the impact of genetic and nongenetic factors on warfarin dose requirements in Egyptians . DNA was extracted from 50 patients taking warfarin for more than 1 year and genotyped for VKORC1 (1173 C> T) , CYP2C9 *3 (1075 C>)gene polymorphisms using SYBR Green - based multiplex allele - specific PCR

Issued also as CD

There are no comments on this title.

to post a comment.